Ingredion Incorporated, produces and sells starches and sweeteners for various industries. The company is headquartered in Westchester, Illinois.
| Revenue (TTM) | $7.21B |
| Gross Profit (TTM) | $1.71B |
| EBITDA | $1.15B |
| Operating Margin | 12.60% |
| Return on Equity | 13.70% |
| Return on Assets | 7.33% |
| Revenue/Share (TTM) | $113.53 |
| Book Value | $71.70 |
| Price-to-Book | 1.35 |
| Price-to-Sales (TTM) | 0.86 |
| EV/Revenue | 0.971 |
| EV/EBITDA | 6.25 |
| Quarterly Earnings Growth (YoY) | -40.50% |
| Quarterly Revenue Growth (YoY) | 0.90% |
| Shares Outstanding | $63.06M |
| Float | $62.58M |
| % Insiders | 0.89% |
| % Institutions | 101.77% |
Volatility is currently expanding
WESTCHESTER, Ill., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its third quarter 2026 financial results for the period ended September 30, 2026, before the market opens Thursday, November 5, 2026.
TRMB, INGR and DE offer exposure to precision agriculture, food innovation and smarter farming technologies shaping the AgTech landscape.
Ingredion's clean-label demand fuels T&HS volume growth and share gains, though rising tapioca costs may pressure near-term benefits.
Ingredion's T&HS growth is powered by clean-label, texture and nutrition demand, with 2026 sales and profit still expected to rise despite cost pressures.
Ingredion's margins remain under pressure as surging tapioca costs outpace pricing despite resilient specialty demand and strong volumes.
Ingredion's LATAM sales rise in Q2, but softer Mexico demand and currency effects hurt margins, with 2026 operating income expected to decline.
Ingredion Incorporated (INGR) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
WESTCHESTER, Ill., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, today announced the appointment of Diego Reynoso as chief financial officer effective October 1, 2026.
CNBC's Jim Cramer, host of Mad Money, posted on X on Monday, “Hard to believe the drug stocks are so out of sync with food stocks.
AgTech and food innovation reshape agriculture and nutrition, putting ADM, DAR and BG firmly in focus.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on INGR and any ticker you trade — then tracks every position and per-strategy win rate.
